(10) Alosetron, a 5-hydroxytryptamine 3 (5HT3) receptor antagonist, has been used to treat IBS-D, (11) but this medication was voluntarily withdrawn from the US market in 2000 due to concerns of ischemic colitis and severe constipation. (12) It was reintroduced in 2002, but can be ...
Thermochemotherapy is a type of cancer treatment that uses both medication and heat radiation to treat patients both locally and systemically. From:Journal of the Neurological Sciences,2022 About this page Add to MendeleySet alert Chapters and Articles ...
doi:10.1016/j.jcpo.2017.03.010Cuomo, Raphael E.Mackey, Tim K.Journal of Cancer PolicyCuomo RE, Mackey TK. The availability of essential cancer medication: An analysis of national formularies. J Cancer Policy 2017;12:49-54.
Medication associated with hearing loss: 25 years of medical malpractice cases in the United States. Many medications have the potential for ototoxicity. To potentiate management of this risk, this study examines malpractice litigation trends of lawsuits i... S Douglas,Ruhl,B Benjamin,... - Otolar...
Medication use (including glucocorticoids, methotrexate, and cyclosporine) was defined as whether the corresponding medication was used or not. We further included additional covariates for selected cancer outcomes. For skin cancer (C43–C44), we additionally adjusted for sun exposure33. Sun exposure ...
Furthermore, the risk of leukemia may be associated with the use of antibiotics or other medications for treating infections and their symptoms, rather than the infections themselves. Determining whether medication use serves as a mediator or directly influences the causal pathway necessitates additional...
Implications for Cancer Survivors. Survivors of breast cancer experience various challenges including anxiety, sleep problems, body pain, fatigue, and fear about the future. The psychological, physical and social factors make a great difference in their quality of life....
initial prescription [21]. Poor adherence to BP medication is associated with a 75% increase in the risk of all-cause mortality [22]. Once a patient is first prescribed medication, they are also likely to remain dependent for life, marking an important treatment crossroad for clinicians [23]...
Women with recurrent epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer are given the medication as maintenance therapy [57]. Talazoparib is a new kind of PARP inhibitor that is also the most potent PARP inhibitor yet reported. Talazoparib can block the activity...
A blood pressure medication was identified as an inhibitor of one of the identified tumor operating pathways. Post- two months of the identified target-specific clinical therapy, the patient went under complete remission while she couldn’t with five years of invasive surgeries, chemotherapies and ...